Targets for Cancer IO A Deep Dive Series - 2023

This new series will include six live webinars addressing gene and cell therapy in immuno-oncology.

Key leaders in the field who are experts in gene or cell therapy will provide an overview of the current state of the science and address questions about its future. An interactive Q&A session will follow the topic overview, providing participants with the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.

Target Audience

Basic, clinical and translational researchers in academia and industry and members of the investment community.

SERIES FLYER

Share this webinar series with your colleagues, download the flyer here.

Enduring Materials

Four weeks following the live webinars, the enduring materials from the webinar, including recording and presentation (as permitted by speakers) will be made available for purchase. Purchase rates can be found in the table below. To purchase enduring materials, please use the button in each webinar box (as the become available). 

To note, for those that registered for/attended the webinar, access is granted immediately following the posting of the materials and can be accessed through the "My Library" button under "The Connect Community" tab at the top of the page. An email will be sent once they are posted following the live program - please allow up to one week for them to be posted.


Registration/Enduring Materials Rates

SITC Member Pricing - Targets for Cancer IO: A Deep Dive

Buy Three, Get The Rest Free

  Live Registration Rates Enduring Materials Rates
Fellow in training/student  $25 per (3 webinars for $75) $12.50 per (3 webinars for $37.50)
Government  $40 per (3 webinars for $120) $20 per (3 webinars for $60)
Health care provider $75 per (3 webinars for $225) $37.50 per (3 webinars for $112.50)
Industry rep  $150 per (3 webinars for $450) $75 per (3 webinars for $225)
Non-profit org/foundation $25 per (3 webinars for $75) $12.50 per (3 webinars for $37.50)
Pharmacist $75 per (3 webinars for $225) $37.50 per (3 webinars for $112.50)
Pharmacist, industry $150 per (3 webinars for $450) $75 per (3 webinars for $225)
Patient/Patient advocate $25 per (3 webinars for $75) $12.50 per (3 webinars for $37.50)
Nurse  $25 per (3 webinars for $75) $12.50 per (3 webinars for $37.50)
Nurse, industry $150 per (3 webinars for $450) $75 per (3 webinars for $225)
Low to lower-middle income economies (non-industry) $0 $0
SITC Non-Member Pricing - Targets for Cancer IO: A Deep Dive
  Live Registration Rates Enduring Materials Rates
Fellow in training/student  $40 per (3 webinars $120) $20 per (3 webinars $60)
Government  $50 per (3 webinars $150) $25 per (3 webinars $75)
Health care provider $100 per (3 webinars $300) $50 per (3 webinars $150)
Industry rep  $300 per (3 webinars $900) $150 per (3 webinars $450)
Non-profit org/foundation $40 per (3 webinars $120) $20 per (3 webinars $60)
Pharmacist $100 per (3 webinars $300) $50 per (3 webinars $150)
Pharmacist, industry $300 per (3 webinars $900) $150 per (3 webinars $450)
Patient/Patient advocate $40 per (3 webinars $120) $20 per (3 webinars $60)
Nurse  $40 per (3 webinars $120) $20 per (3 webinars $60)
Nurse, industry $300 per (3 webinars $900) $150 per (3 webinars $450)
Low to lower-middle income economies (non-industry) $25 $12.50 

Acknowledgements

Targets for Cancer IO: A Deep Dive Series 3 is supported, in part, by grants from Genentech, a member of the Roche Group, and Kite.GenentechKite

Interested in Supporting this program?

Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.


Browse Webinars

As an added benefit, SITC members will be eligible to receive a discount on the full series, as well as individual seminars, if purchased separately. Additionally, at the time of registration, if three of the six webinars are purchased, you are able to register for the remainder at no additional cost.

LIVE WEBINAR 1

Identification of Tumor Reactive T Cells Deconvoluting the TCR Specificity


Date of Live Event
Wednesday, July 5, 2023 – 12–2 p.m. EDT

Moderators

Alena Gros, PhD
Vall d'Hebron Institute of Oncology (V.H.I.O.)

Giacomo Oliveira, PhD
Dana-Farber Cancer Institute

Faculty

Stephen J. Elledge, PhD
Harvard Medical School

Cristina Puig-Saus, PhD 
University of California, Los Angeles

LIVE WEBINAR 2

Multiple Gene Modification and T Cells 


Date of Live Event
Monday, Aug. 28, 2023 – 12–2 p.m. EDT

Moderators

Gay Crooks, MBBS
University of California, Los Angeles

Katy Rezvani, MD, PhD
The University of Texas MD Anderson Cancer Center

Faculty

Justin Eyquem, PhD 

University of California, San Francisco

Julia Carnevale, MD 

University of California, San Francisco

May Daher, MD
The University of Texas MD Anderson Cancer Center

LIVE WEBINAR 3

Modulation of Tregs in Clinical Trials


Date of Live Event

Friday, Sept. 22, 2023 – 12–2 p.m. EDT

Moderators

Aurélien Marabelle, MD, PhD
Gustave Roussy

Sergio A. Quezada, PhD
University College London

Faculty

Pan Zheng, MD, PhD
OncoC4, Inc.

Vaios Karanikas, PhD
Roche Innovation Center Zurich

Shimon Sakaguchi, MD, PhD
Kyoto University

Peter Luo, PhD
Adagene Inc.

LIVE WEBINAR 4

Epigenetic Modulation of T Cell States in Adoptive Cell Therapy


Date of Live Event
Tuesday, Sept. 26, 2023 – 2:30 p.m.–4:30 p.m. EDT

Moderators

Andrea Schietinger, PhD
Memorial Sloan Kettering Cancer Center

E. John Wherry, PhD
University of Pennsylvania

Faculty

Benjamin Youngblood, PhD
St. Jude Children's Research Hospital

Mary Philip, MD, PhD
Vanderbilt University Medical Center

Debattama Sen, PhD
Massachusetts General Hospital/Harvard Medical School

Ansuman Satpathy, MD, PhD
Stanford University School of Medicine

LIVE WEBINAR 5

What are the Root Causes of Immune Deserts? 


Date of Live Event
Wednesday, Oct. 11, 2023 – 12–2 p.m. EDT

Moderators

Elizabeth Jaffee, MD, FAIO
Kimmel Cancer Center at Johns Hopkins

Luciana Molinero, PhD
Genentech

Faculty

Evanthia Roussos Torres, MD, PhD
University of Southern California

Christine Moussion, PhD
Genentech

Mikala Egeblad, PhD
Cold Spring Harbor Laboratory

LIVE WEBINAR 6

Advances in CAR-T Engineering for Activity in Solid Tumors


Date of Live Event
Friday, Dec. 15, 2023 – 2:30 p.m.–4:30 p.m. EST

Moderators

John Haanen, MD, PhD
Netherlands Cancer Institute

Marcela Maus, MD, PhD
Harvard University

Faculty

Robbie Majzner, MD
Dana Farber Cancer Institute/Boston Children’s Hospital

Yvonne Chen, PhD
University of California, Los Angeles




View Past Programs

2022

2021